# Bausch Health Companies Inc.: filings

BHC · NYSE · CIK 885590 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhc.md) · [Financials](/companies/bhc/financials.md) · [Filings](/companies/bhc/filings.md) · [Insiders](/companies/bhc/insiders.md)

## Reports and events: 538 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1074, 8-K 345, 425 137, 3 86, 10-Q 50, 4/A 46, 6-K 42, SC 13D/A 37, SC TO-T/A 34, SC TO-C 26, CORRESP 24, DEFA14A 24, UPLOAD 23, DEF 14A 18, SC 13G/A 18, 10-K 17, 144 14, DFAN14A 14, SC 13G 13, SD 13, 8-K/A 12, ARS 10, S-8 9, SC 13D 9, 3/A 6, SC TO-T 6, CT ORDER 5, SCHEDULE 13D/A 5, 424B5 4, S-4/A 4, PRER14A 3, PRE 14A 2, PRRN14A 2, S-3ASR 2, S-4 2, S-8 POS 2, SCHEDULE 13G/A 2, 10-Q/A 1, 20-F 1, 8-A12B 1, 8-A12B/A 1, CERT 1, DEFC14A 1, EFFECT 1, FWP 1, NT 10-K 1, NT 10-Q 1, PREC14A 1, PREM14A 1, RW 1, S-3D 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 20:11 ET | [10-Q](/filings/0000885590-26-000107.md) | Quarterly report, period 2026-06-30 | 0000885590-26-000107 |
| 2026-07-29 | 20:11 ET | [8-K](/filings/0000885590-26-000105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000105 |
| 2026-07-01 | 20:23 ET | [8-K](/filings/0000885590-26-000089.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885590-26-000089 |
| 2026-05-19 | 20:18 ET | [8-K](/filings/0000885590-26-000057.md) | 5.07 Shareholder vote results | 0000885590-26-000057 |
| 2026-04-30 | 22:12 ET | [10-Q](/filings/0000885590-26-000053.md) | Quarterly report, period 2026-03-31 | 0000885590-26-000053 |
| 2026-04-29 | 20:10 ET | [8-K](/filings/0000885590-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000051 |
| 2026-04-08 | 20:05 ET | [DEF 14A](/filings/0001140361-26-013816.md) | Proxy statement, period 2026-05-19 | 0001140361-26-013816 |
| 2026-03-02 | 22:17 ET | [8-K](/filings/0001193125-26-085755.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-085755 |
| 2026-02-19 | 23:10 ET | [10-K](/filings/0000885590-26-000023.md) | Annual report, period 2025-12-31 | 0000885590-26-000023 |
| 2026-02-18 | 21:12 ET | [8-K](/filings/0000885590-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000020 |
| 2026-01-23 | 21:06 ET | [8-K](/filings/0000885590-26-000008.md) | 7.01 Regulation FD disclosure | 0000885590-26-000008 |
| 2026-01-13 | 12:01 ET | [8-K](/filings/0000885590-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000885590-26-000005 |
| 2026-01-02 | 21:15 ET | [8-K](/filings/0000950103-26-000052.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-000052 |
| 2025-12-29 | 12:32 ET | [8-K](/filings/0000885590-25-000059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885590-25-000059 |
| 2025-12-23 | 22:27 ET | [8-K](/filings/0000885590-25-000057.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000057 |
| 2025-12-12 | 22:30 ET | [8-K](/filings/0000950103-25-016089.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-016089 |
| 2025-12-09 | 00:30 ET | [8-K](/filings/0000885590-25-000054.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000054 |
| 2025-11-24 | 12:10 ET | [8-K](/filings/0001193125-25-291998.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-291998 |
| 2025-10-30 | 22:09 ET | [10-Q](/filings/0000885590-25-000051.md) | Quarterly report, period 2025-09-30 | 0000885590-25-000051 |
| 2025-10-29 | 20:09 ET | [8-K](/filings/0000885590-25-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000048 |
| 2025-10-09 | 11:02 ET | [8-K](/filings/0000885590-25-000044.md) | 5.07 Shareholder vote results | 0000885590-25-000044 |
| 2025-09-11 | 13:52 ET | [8-K](/filings/0001193125-25-200869.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-200869 |
| 2025-08-27 | 20:26 ET | [DEF 14A](/filings/0001140361-25-032962.md) | Proxy statement, period 2025-10-07 | 0001140361-25-032962 |
| 2025-08-15 | 19:18 ET | [8-K](/filings/0001193125-25-181736.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-181736 |
| 2025-08-15 | 13:39 ET | [SCHEDULE 13D/A](/filings/0001539497-25-002158.md) | Ownership report, active investor, amended | 0001539497-25-002158 |
| 2025-08-14 | 01:38 ET | [SCHEDULE 13D/A](/filings/0001013594-25-001066.md) | Ownership report, active investor, amended | 0001013594-25-001066 |
| 2025-07-31 | 22:36 ET | [10-Q](/filings/0000885590-25-000032.md) | Quarterly report, period 2025-06-30 | 0000885590-25-000032 |
| 2025-07-30 | 20:12 ET | [8-K](/filings/0000885590-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000030 |
| 2025-07-29 | 11:01 ET | [8-K](/filings/0001193125-25-167131.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-167131 |
| 2025-07-24 | 12:15 ET | [8-K](/filings/0001193125-25-163860.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-163860 |
| 2025-07-10 | 20:15 ET | [8-K](/filings/0001193125-25-157612.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157612 |
| 2025-06-27 | 11:37 ET | [8-K](/filings/0001193125-25-149731.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-149731 |
| 2025-06-18 | 20:58 ET | [8-K](/filings/0000950103-25-007605.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007605 |
| 2025-06-17 | 20:39 ET | [SCHEDULE 13D/A](/filings/0001013594-25-000763.md) | Ownership report, active investor, amended | 0001013594-25-000763 |
| 2025-06-10 | 13:10 ET | [8-K](/filings/0000950103-25-007190.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007190 |
| 2025-05-21 | 23:39 ET | [SCHEDULE 13D/A](/filings/0001013594-25-000695.md) | Ownership report, active investor, amended | 0001013594-25-000695 |
| 2025-05-21 | 20:45 ET | [SCHEDULE 13D/A](/filings/0001539497-25-001480.md) | Ownership report, active investor, amended | 0001539497-25-001480 |
| 2025-05-21 | 00:15 ET | [8-K](/filings/0001193125-25-123366.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-123366 |
| 2025-05-15 | 20:10 ET | [8-K](/filings/0001193125-25-120802.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-120802 |
| 2025-05-14 | 20:20 ET | [8-K](/filings/0000885590-25-000022.md) | 5.07 Shareholder vote results | 0000885590-25-000022 |
| 2025-05-01 | 22:03 ET | [10-Q](/filings/0000885590-25-000020.md) | Quarterly report, period 2025-03-31 | 0000885590-25-000020 |
| 2025-04-30 | 20:11 ET | [8-K](/filings/0000885590-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000018 |
| 2025-04-15 | 11:38 ET | [8-K](/filings/0001193125-25-080728.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-080728 |
| 2025-04-09 | 21:35 ET | [8-K](/filings/0001193125-25-075911.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-075911 |
| 2025-04-07 | 21:19 ET | [SCHEDULE 13D](/filings/0000902664-25-001705.md) | Ownership report, active investor | 0000902664-25-001705 |
| 2025-04-02 | 20:05 ET | [DEF 14A](/filings/0001140361-25-011851.md) | Proxy statement, period 2025-05-13 | 0001140361-25-011851 |
| 2025-03-25 | 18:40 ET | [8-K](/filings/0000885590-25-000013.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000013 |
| 2025-03-19 | 15:57 ET | [8-K](/filings/0000885590-25-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000010 |
| 2025-02-20 | 00:32 ET | [10-K](/filings/0000885590-25-000007.md) | Annual report, period 2024-12-31 | 0000885590-25-000007 |
| 2025-02-19 | 21:25 ET | [8-K](/filings/0000885590-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000004 |

Page 1 of 11. [Older](/companies/bhc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.